{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:08:19Z","timestamp":1740114499145,"version":"3.37.3"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.toxlet.2024.04.014","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T02:21:41Z","timestamp":1714702901000},"page":"103-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pharmacokinetics and pharmacodynamics of standard nerve agent medical countermeasures in G\u00f6ttingen Minipigs"],"prefix":"10.1016","volume":"397","author":[{"given":"Jeffrey L.","family":"Langston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.","family":"Moffett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Ross","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd M.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2024.04.014_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.vascn.2017.02.022","article-title":"Ion currents of cardiomyocytes in different regions of the Gottingen minipig heart","volume":"86","author":"Arlock","year":"2017","journal-title":"J. Pharm. Toxicol. Methods"},{"key":"10.1016\/j.toxlet.2024.04.014_bib2","first-page":"425","article-title":"Effects of oximes, diacetylmonoxime, pyridine-2-aldoxime, and pyridine-2-aldoxime methochloride, on the electrical and mechanical activities of guinea pig cardiac ventricular muscles","volume":"8","author":"Atoda","year":"1985","journal-title":"J. Pharm."},{"key":"10.1016\/j.toxlet.2024.04.014_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.vascn.2011.04.007","article-title":"Cardiovascular and respiratory safety pharmacology in G\u00f6ttingen minipigs: pharmacological characterization","volume":"64","author":"Authier","year":"2011","journal-title":"J. Pharm. Toxicol. Methods"},{"key":"10.1016\/j.toxlet.2024.04.014_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0014-2999(72)90148-3","article-title":"Cardiac and peripheral vascular effects of pralidoxime chloride","volume":"20","author":"Barnes","year":"1972","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.toxlet.2024.04.014_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00609698","article-title":"Intramuscular bioavailability of chlorazepate as compared to diazepam","volume":"28","author":"Bertler","year":"1985","journal-title":"Eur. J. Clin. Pharm."},{"key":"10.1016\/j.toxlet.2024.04.014_bib6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/10915818211040487","article-title":"Combined cardiopulmonary assessments using impedance and digital implants in conscious freely moving cynomolgus monkeys, beagle dogs, and g\u00f6ttingen minipigs: pharmacological characterization and social housing effects","volume":"40","author":"Boulay","year":"2021","journal-title":"Int J. Toxicol."},{"key":"10.1016\/j.toxlet.2024.04.014_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.665644","article-title":"Hepatic cytochrome P450 abundance and activity in the developing and adult gottingen minipig: pivotal data for PBPK modeling","volume":"12","author":"Buyssens","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.toxlet.2024.04.014_bib8","first-page":"218","article-title":"Alteration in calcium metabolism as a mechanism for pyridine aldoxime methochloride (2-PAM) cardiac action in rabbit atria","volume":"193","author":"Carrier","year":"1975","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.toxlet.2024.04.014_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1440-1681.1978.tb00662.x","article-title":"Pressor action of pyridine-2-aldoxime in malathion poisoning","volume":"5","author":"Chang","year":"1978","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"10.1016\/j.toxlet.2024.04.014_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115650","article-title":"A delayed treatment model for the evaluation of scopolamine for VX nerve agent intoxication","volume":"427","author":"Cornelissen","year":"2021","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.toxlet.2024.04.014_bib11","article-title":"Utility of G\u00f6ttingen minipigs for the prediction of human pharmacokinetic profiles after intravenous drug administration","volume":"41","author":"Ding","year":"2021","journal-title":"Drug Metab. Pharm."},{"key":"10.1016\/j.toxlet.2024.04.014_bib12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/01480548509041068","article-title":"Atropine sulfate and 2-pyridine aldoxime methylchloride elicit stress-induced convulsions and lethality in mice and guinea pigs","volume":"8","author":"Donzanti","year":"1985","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.toxlet.2024.04.014_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tox.2006.09.013","article-title":"Swine models in the design of more effective medical countermeasures against organophosphorus poisoning","volume":"233","author":"Dorandeu","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.toxlet.2024.04.014_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.vascn.2010.05.006","article-title":"Welfare of the minipig with special reference to use in regulatory toxicology studies","volume":"62","author":"Ellegaard","year":"2010","journal-title":"J. Pharm. Toxicol. Methods"},{"year":"2018","series-title":"Guidance for Industry: Bioanalytical Method Validation","key":"10.1016\/j.toxlet.2024.04.014_bib15"},{"year":"2005","series-title":"Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers","key":"10.1016\/j.toxlet.2024.04.014_bib16"},{"year":"1982","series-title":"Pharmacokinetics","author":"Gibaldi","key":"10.1016\/j.toxlet.2024.04.014_bib17"},{"key":"10.1016\/j.toxlet.2024.04.014_bib18","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM197411072911906","article-title":"Drug therapy. Benzodiazepines (first of two parts)","volume":"291","author":"Greenblatt","year":"1974","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.toxlet.2024.04.014_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/milmed\/147.2.122","article-title":"Effects of atropine sulfate and pralidoxime chloride on visual, physiological, performance, subjective, and cognitive variables in man: a review","volume":"147","author":"Headley","year":"1982","journal-title":"Mil. Med."},{"key":"10.1016\/j.toxlet.2024.04.014_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/08958370500306131","article-title":"Comparison of low-level sarin and cyclosarin vapor exposure on pupil size of the Gottingen minipig: effects of exposure concentration and duration","volume":"18","author":"Hulet","year":"2006","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.toxlet.2024.04.014_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/08958378.2013.872212","article-title":"Comparison of sarin and cyclosarin toxicity by subcutaneous, intravenous and inhalation exposure in Gottingen minipigs","volume":"26","author":"Hulet","year":"2014","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.toxlet.2024.04.014_bib22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/BF03018105","article-title":"Comparative absorption kinetics of intramuscular midazolam and diazepam","volume":"43","author":"Hung","year":"1996","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.toxlet.2024.04.014_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015076","article-title":"Effects of different doses of pralidoxime administered during cardiopulmonary resuscitation and the role of alpha-adrenergic receptors in its pressor action","volume":"9","author":"Jung","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.toxlet.2024.04.014_bib24","first-page":"427","article-title":"Plasma concentrations of diazepam and its metabolites after peroral, intramuscular, and rectal administration. Correlation between plasma concentration and sedatory effect of diazepam","volume":"12","author":"Kanto","year":"1975","journal-title":"Int J. Clin. Pharm. Biopharm."},{"key":"10.1016\/j.toxlet.2024.04.014_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/rvsc.2001.0458","article-title":"Analysis of respiratory mechanics by impulse oscillometry in non-sedated and diazepam-sedated swine","volume":"70","author":"Klein","year":"2001","journal-title":"Res Vet. Sci."},{"key":"10.1016\/j.toxlet.2024.04.014_bib26","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/bja\/47.8.857","article-title":"Absorption and sedative effects of diazepam after oral administration and intramuscular administration into the vastus lateralis muscle and the deltoid muscle","volume":"47","author":"Korttila","year":"1975","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.toxlet.2024.04.014_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0773.1976.tb03161.x","article-title":"Polyethylene glycol as a solvent for diazepam: bioavailability and clinical effects after intramuscular administration, comparison of oral, intramuscular and rectal administration, and precipitation from intravenous solutions","volume":"39","author":"Korttila","year":"1976","journal-title":"Acta Pharm. Toxicol. (Copenh)"},{"key":"10.1016\/j.toxlet.2024.04.014_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1124\/jpet.120.265843","article-title":"Oral pretreatment with galantamine effectively mitigates the acute toxicity of a supralethal dose of soman in cynomolgus monkeys posttreated with conventional antidotes","volume":"375","author":"Lane","year":"2020","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.toxlet.2024.04.014_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.toxlet.2016.10.011","article-title":"VX toxicity in the Gottingen minipig","volume":"264","author":"Langston","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2024.04.014_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.vascn.2010.10.001","article-title":"Characterization of cardiac repolarization in the G\u00f6ttingen minipig","volume":"63","author":"Laursen","year":"2011","journal-title":"J. Pharm. Toxicol. Methods"},{"key":"10.1016\/j.toxlet.2024.04.014_bib31","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s11095-016-1982-5","article-title":"Characterization of pharmacokinetics in the G\u00f6ttingen Minipig with reference human drugs: an in vitro and in vivo approach","volume":"33","author":"Lignet","year":"2016","journal-title":"Pharm. Res"},{"key":"10.1016\/j.toxlet.2024.04.014_bib32","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.toxrep.2021.04.005","article-title":"Soman-induced toxicity, cholinesterase inhibition and neuropathology in adult male Gottingen minipigs","volume":"8","author":"Lumley","year":"2021","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.toxlet.2024.04.014_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd5758","article-title":"Importance of the pig as a human biomedical model","volume":"13","author":"Lunney","year":"2021","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.toxlet.2024.04.014_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2022.107221","article-title":"Electrocardiography and heart rate variability in G\u00f6ttingen Minipigs: impact of diurnal variation, lead placement, repeatability and streptozotocin-induced diabetes","volume":"118","author":"Lyhne","year":"2022","journal-title":"J. Pharm. Toxicol. Methods"},{"key":"10.1016\/j.toxlet.2024.04.014_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0773.1979.tb02365.x","article-title":"Absorption of diazepam in man following rectal and parenteral administration","volume":"45","author":"Magnussen","year":"1979","journal-title":"Acta Pharm. Toxicol. (Copenh)"},{"key":"10.1016\/j.toxlet.2024.04.014_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.vascn.2008.12.004","article-title":"Validation of the normal, freely moving G\u00f6ttingen minipig for pharmacological safety testing","volume":"60","author":"Markert","year":"2009","journal-title":"J. Pharm. Toxicol. Methods"},{"key":"10.1016\/j.toxlet.2024.04.014_bib37","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1080\/01480545.2021.1916171","article-title":"Anticonvulsant effectiveness of scopolamine against soman-induced seizures in African green monkeys","volume":"45","author":"McDonough","year":"2022","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.toxlet.2024.04.014_bib38","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/1091581818779362","article-title":"Behavioral, pharmacokinetic, and cardiovascular evaluation of candidate oximes in African green monkeys","volume":"37","author":"Moffett","year":"2018","journal-title":"Int J. Toxicol."},{"key":"10.1016\/j.toxlet.2024.04.014_bib39","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.annemergmed.2012.05.013","article-title":"Rapid and complete bioavailability of antidotes for organophosphorus nerve agent and cyanide poisoning in minipigs after intraosseous administration","volume":"60","author":"Murray","year":"2012","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.toxlet.2024.04.014_bib40","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/bdd.2510160804","article-title":"Pharmacokinetics of HI-6 and atropine in anaesthetized pigs after administration by a new autoinjector","volume":"16","author":"Nyberg","year":"1995","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.toxlet.2024.04.014_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0928-0987(00)00091-9","article-title":"Evaluation of G\u00f6ttingen minipig skin for transdermal in vitro permeation studies","volume":"11","author":"Qvist","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.toxlet.2024.04.014_bib42","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.1177\/1091581813488632","article-title":"MMB4 DMS: cardiovascular and pulmonary effects on dogs and neurobehavioral effects on rats","volume":"32","author":"Roche","year":"2013","journal-title":"Int J. Toxicol."},{"key":"10.1016\/j.toxlet.2024.04.014_bib43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cbi.2015.07.001","article-title":"Prophylaxis with human serum butyrylcholinesterase protects Gottingen minipigs exposed to a lethal high-dose of sarin vapor","volume":"238","author":"Saxena","year":"2015","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.toxlet.2024.04.014_bib44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cbi.2008.05.022","article-title":"Efficacy of human serum butyrylcholinesterase against sarin vapor","volume":"175","author":"Saxena","year":"2008","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.toxlet.2024.04.014_bib45","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.bcp.2011.09.019","article-title":"Pretreatment with human serum butyrylcholinesterase alone prevents cardiac abnormalities, seizures, and death in Gottingen minipigs exposed to sarin vapor","volume":"82","author":"Saxena","year":"2011","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.toxlet.2024.04.014_bib46","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/jps.21916","article-title":"Significance of protein binding in pharmacokinetics and pharmacodynamics","volume":"99","author":"Schmidt","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.toxlet.2024.04.014_bib47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0773.1968.tb00444.x","article-title":"A comparison of the potency of adrenaline and noradrenaline in delaying absorption from muscles","volume":"26","author":"Schou","year":"1968","journal-title":"Acta Pharm. Toxicol. (Copenh)"},{"key":"10.1016\/j.toxlet.2024.04.014_bib48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cpt197011168","article-title":"Modification of the effects of atropine on human heart rate by pralidoxime","volume":"11","author":"Sidell","year":"1970","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.toxlet.2024.04.014_bib49","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0272-0590(91)90094-K","article-title":"Pharmacokinetics and pharmacodynamics of oximes in unanesthetized pigs","volume":"16","author":"Stemler","year":"1991","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.toxlet.2024.04.014_bib50","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.vascn.2008.02.001","article-title":"Evaluation of cardiovascular and ECG parameters in the normal, freely moving Gottingen Minipig","volume":"57","author":"Stubhan","year":"2008","journal-title":"J. Pharm. Toxicol. Methods"},{"key":"10.1016\/j.toxlet.2024.04.014_bib51","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2125.1988.tb03346.x","article-title":"Respiratory and cardiovascular effects in relation to plasma levels of midazolam and diazepam","volume":"25","author":"Sunzel","year":"1988","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.toxlet.2024.04.014_bib52","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/0300985811402846","article-title":"Swine as models in biomedical research and toxicology testing","volume":"49","author":"Swindle","year":"2012","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.toxlet.2024.04.014_bib53","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bcpt.12410","article-title":"Age-related differences in CYP3A abundance and activity in the liver of the G\u00f6ttingen Minipig","volume":"117","author":"Van Peer","year":"2015","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"10.1016\/j.toxlet.2024.04.014_bib54","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/milmed\/153.9.470","article-title":"Effects of atropine, 2-PAM, or pyridostigmine in euvolemic or hemorrhagic conscious swine","volume":"153","author":"Wade","year":"1988","journal-title":"Mil. Med"},{"key":"10.1016\/j.toxlet.2024.04.014_bib55","first-page":"464","article-title":"Novel technique for retroperitoneal implantation of telemetry transmitters for physiologic monitoring in Gottingen minipigs (Sus scrofa domesticus)","volume":"64","author":"Willens","year":"2014","journal-title":"Comp. Med"},{"key":"10.1016\/j.toxlet.2024.04.014_bib56","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s11095-017-2247-7","article-title":"Utility of G\u00f6ttingen minipigs for prediction of human pharmacokinetic profiles after dermal drug application","volume":"34","author":"Yamamoto","year":"2017","journal-title":"Pharm. Res"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427424000845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427424000845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T02:04:25Z","timestamp":1718244265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427424000845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":56,"alternative-id":["S0378427424000845"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2024.04.014","relation":{},"ISSN":["0378-4274"],"issn-type":[{"type":"print","value":"0378-4274"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics and pharmacodynamics of standard nerve agent medical countermeasures in G\u00f6ttingen Minipigs","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2024.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}